Advance the development of your therapeutic for metabolic dysfunction-associated steatohepatitis (MASH) or metabolic dysfunction-associated steatotic liver disease (MASLD) with an experienced team. We provide tailored, data-driven solutions to ensure the success of your trial. Learn more about our strategic clinical development services, scientific expertise, and strong relationships with KOLs and sites.
Learn more about our capabilities in:
- Specialized Liver Imaging: MRI-PDFF, MR elastography, cT1, and more for accurate assessment and monitoring
- Core Lab Partnerships: Integrating bioanalytical labs for PK/PD, biomarker analysis, and pathology to enhance trial precision
- Enhanced Scientific & Medical Expertise: Superior protocol design, preclinical compound strategy support, and full-service Phase I-IV trial management
- Global Network and Industry Relationships: Access to 4,000 MASH/MASLD sites and top investigators for robust trial execution